Wegovy in Australia: Cost, Availability, and How It’s Different from Ozempic

Wegovy, a higher-dose version of semaglutide designed specifically for weight loss, officially launched in Australia in August 2024. While it shares the same active ingredient as Ozempic, its intended use, dosing, and accessibility are different — especially when it comes to pricing and insurance.

Here’s what Australians need to know about this new weight-loss medication.

What Is Wegovy?

Wegovy is a once-weekly injectable prescription medication used for chronic weight management in adults with obesity or overweight and at least one weight-related condition (e.g., hypertension, high cholesterol, type 2 diabetes).

It works by mimicking a natural hormone called GLP-1, which regulates appetite and helps people feel fuller for longer. The result is reduced calorie intake and significant weight loss over time.

Wegovy vs Ozempic

Though both contain semaglutide, the major differences are:

• Dose: Wegovy is available in higher doses (up to 2.4 mg weekly), while Ozempic typically maxes out at 1.0 mg
• Intended Use: Ozempic is approved for type 2 diabetes; Wegovy is approved for obesity treatment
• PBS Coverage: As of now, Ozempic is subsidised by the PBS for diabetes, but Wegovy is not covered and must be purchased privately

For a detailed breakdown, see Ozempic vs Wegovy vs Mounjaro: What’s the Difference?

Cost of Wegovy in Australia

Because Wegovy is not on the Pharmaceutical Benefits Scheme (PBS), users must pay the full price out of pocket. The current average cost is:

• A$400–460 per pen (monthly dose)
• No concession or government discount available

This makes Wegovy significantly more expensive than Ozempic for those eligible for diabetes subsidies.

Availability and Shortages

Wegovy launched in Australia just as global supply issues with GLP-1 medications reached new heights. Although some pharmacies stock Wegovy, many patients report delays or are placed on waiting lists.

Doctors are advised to prioritise patients with obesity-related conditions and to monitor for side effects during the initial dose escalation phase.

Who Is Eligible?

Wegovy is approved for use in adults who:

• Have a BMI ≥ 30, or
• Have a BMI ≥ 27 with a weight-related condition (e.g., sleep apnea, high blood pressure)

A valid prescription from a GP or specialist is required.

Is Wegovy Covered by Insurance?

Private health insurers may partially cover the cost of doctor consultations or nutrition support, but not the medication itself. Efforts are underway to add GLP-1 drugs like Wegovy to Australia’s PBS for weight-loss treatment, but no changes have been approved.

For people paying privately, it’s important to budget for long-term use — studies show weight returns if the medication is stopped abruptly.

Side Effects and Considerations

Common side effects include nausea, constipation, headache, and fatigue — especially during the first few weeks. Gradual dose increases help minimise discomfort.

Long-term safety appears strong, but it’s still advised to combine Wegovy with dietary support and physical activity.

Bottom Line

Wegovy offers Australians a powerful new tool for weight loss, especially for those struggling with obesity-related health risks. However, its high cost, limited availability, and lack of public subsidy mean that access is still restricted for many.

If you’re considering Wegovy, speak with your doctor to determine if you’re eligible, and compare options like What Is Ozempic? or What Is Mounjaro to see what’s best for your health goals and budget.

Suggested Reads

More from Healthy Living Magazine:

• How to Get Ozempic and Wegovy in Australia: Cost, Access, and Weight Loss Info
• Wegovy vs Ozempic: What’s the Difference?
• Ozempic vs Wegovy vs Mounjaro: What’s the Difference?
• Tirzepatide vs Semaglutide: Weight Loss Benefits Explained

External Sources:

• Australian Public Assessment Report: Wegovy
• Pharmaceutical Benefits Scheme Australia
• Ozempic can cost almost $2000 a year. An Australian …
• Are you a patient currently receiving treatment with Wegovy^®? Find out more information on the wegovycare^® website